Log in to save to my catalogue

Regulation of estrogen signaling and breast cancer proliferation by an ubiquitin ligase TRIM56

Regulation of estrogen signaling and breast cancer proliferation by an ubiquitin ligase TRIM56

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6473003

Regulation of estrogen signaling and breast cancer proliferation by an ubiquitin ligase TRIM56

About this item

Full title

Regulation of estrogen signaling and breast cancer proliferation by an ubiquitin ligase TRIM56

Publisher

London: Nature Publishing Group UK

Journal title

Oncogenesis (New York, NY), 2019-04, Vol.8 (5), p.30-30, Article 30

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Breast cancer ranks no. 1 in women cancer worldwide, while 60–70% are estrogen receptor alpha positive. The estrogen selective modulators, such as tamoxifen, become the effective drugs for controlling ER alpha breast cancer progression. However, tamoxifen resistance will develop during long-time treatment and cancer progression. Thus, further under...

Alternative Titles

Full title

Regulation of estrogen signaling and breast cancer proliferation by an ubiquitin ligase TRIM56

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6473003

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6473003

Other Identifiers

ISSN

2157-9024

E-ISSN

2157-9024

DOI

10.1038/s41389-019-0139-x

How to access this item